Long overdue, for sure, considering we effectively paid for the drug to be made.
I wonder what standard will be used to determine if the price is too high. From the article, it says
Under the draft roadmap, seen by Reuters, the government will consider factors including whether only a narrow set of patients can afford the drug, and whether drugmakers are exploiting a health or safety issue by hiking prices.
But I don’t have faith the government will do enough. The oversight over this just doesn’t feel like it will be enforced as much as it should.